Regulation - GlaxoSmithKline, Hematology

Filter

Current filters:

GlaxoSmithKlineHematology

Popular Filters

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top